摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-iodo-1-(2-methylphenyl)-1H-1,2,3-triazole | 1086032-23-6

中文名称
——
中文别名
——
英文名称
4-iodo-1-(2-methylphenyl)-1H-1,2,3-triazole
英文别名
4-Iodo-1-(2-methylphenyl)triazole
4-iodo-1-(2-methylphenyl)-1H-1,2,3-triazole化学式
CAS
1086032-23-6
化学式
C9H8IN3
mdl
——
分子量
285.087
InChiKey
PWEFIMUBOILTBZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    30.7
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    4-iodo-1-(2-methylphenyl)-1H-1,2,3-triazoleN-Boc-1,2,5,6-四氢吡啶-4-硼酸频哪醇酯1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以105 mg的产率得到tert-butyl 4-[1-(2-methylphenyl)-1H-1,2,3-triazol-4-yl]-3,6-dihydropyridine-1(2H)-carboxylate
    参考文献:
    名称:
    Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist
    摘要:
    We describe here the discovery and the structure-activity relationship (SAR) of a series of 4-(1-Aryl-triazol-4- yl)-tetrahydropyridines as novel mGluR1 antagonists. Our extensive chemical modi. cation of lead compound 2 successfully led to fluoropyridine analogs 7j and 1 with improved in vivo antagonistic activities. Among the evaluated compounds, chemically stable urea analog 1 showed oral antagonistic activity at dose ranges of 10-30 mg/kg in an animal model. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.09.060
  • 作为产物:
    描述:
    1-(2-methylphenyl)-4-(tributylstannyl)-1H-1,2,3-triazole 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以344 mg的产率得到4-iodo-1-(2-methylphenyl)-1H-1,2,3-triazole
    参考文献:
    名称:
    Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist
    摘要:
    We describe here the discovery and the structure-activity relationship (SAR) of a series of 4-(1-Aryl-triazol-4- yl)-tetrahydropyridines as novel mGluR1 antagonists. Our extensive chemical modi. cation of lead compound 2 successfully led to fluoropyridine analogs 7j and 1 with improved in vivo antagonistic activities. Among the evaluated compounds, chemically stable urea analog 1 showed oral antagonistic activity at dose ranges of 10-30 mg/kg in an animal model. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.09.060
点击查看最新优质反应信息